130 related articles for article (PubMed ID: 173652)
1. Influence of fatty acids on pressor responses to catecholamines.
Chopde CT; Brahmankar DM; Jadhav SS; Hardas AP; Dorle AK
Indian J Physiol Pharmacol; 1975; 19(3):146-51. PubMed ID: 173652
[TBL] [Abstract][Full Text] [Related]
2. Theophylline potentiation of in vitro effects of ACTH and catecholamines in rabbit adipose tissue.
Mühlbachová E; Miseková D; Wenkeová J; Wenke M
Physiol Bohemoslov; 1973; 22(5):513-24. PubMed ID: 4360410
[No Abstract] [Full Text] [Related]
3. Potentiation by SKF 525A of the pressor responses to catecholamines, oxytocin and carotid occlusion in rats.
Krstić MK
Arch Int Pharmacodyn Ther; 1984 May; 269(1):52-62. PubMed ID: 6466007
[TBL] [Abstract][Full Text] [Related]
4. Effect of endotoxin and trypsin on the blood pressor response to catecholamines in normo- and hypothermic rabbits.
Csákó G; Szilágyi T; Csernyánszky H; Tóth S
Med Biol; 1976 Aug; 54(4):243-53. PubMed ID: 785125
[TBL] [Abstract][Full Text] [Related]
5. Influence of diphtheria toxin on free fatty acid mobilization and pressor responses to catecholamines.
Brahmankar DM; Umathe SN; Chopde CT
Mater Med Pol; 1976; 8(4):392-6. PubMed ID: 1027953
[No Abstract] [Full Text] [Related]
6. Influence of catecholamines on some of the important carbohydrate and lipid intermediary metabolites during their pressor responses.
Chopde CT; Brahmankar DM; Dorle AK
Biochem Pharmacol; 1973 Mar; 22(5):575-80. PubMed ID: 4692168
[No Abstract] [Full Text] [Related]
7. Potentiation by hydrocortisone of responses to catecholamines in vascular smooth muscle.
Besse JC; Bass AD
J Pharmacol Exp Ther; 1966 Nov; 154(2):224-38. PubMed ID: 5922985
[No Abstract] [Full Text] [Related]
8. Potentiation of the cardiovascular effects of some catecholamines by a monoamine oxidase inhibitor.
Cuthbert MF; Vere DW
Br J Pharmacol; 1971 Oct; 43(2):471P-472P. PubMed ID: 5158241
[No Abstract] [Full Text] [Related]
9. Cardiovascular responses to catecholamines at 12 degrees C in the American bullfrog (Rana catesbeiana).
Herman CA; Robleto DO; Mata PL; Heller RS
J Exp Zool; 1986 Oct; 240(1):17-23. PubMed ID: 3490539
[TBL] [Abstract][Full Text] [Related]
10. [Effect of several catecholamines on pulmonary circulation].
Tsybenko VA; Navakatikian MA
Fiziol Zh SSSR Im I M Sechenova; 1977 May; 63(5):707-14. PubMed ID: 196946
[TBL] [Abstract][Full Text] [Related]
11. Selective augmentation of the pressor responses to catecholamines by metanephrine.
Allen DO; Calvert DN; Lum BK
J Pharmacol Exp Ther; 1969 Jun; 167(2):309-18. PubMed ID: 4306903
[No Abstract] [Full Text] [Related]
12. Neuropeptide tyrosine (NPY)-induced potentiation of the pressor activity of catecholamines in conscious rats.
López LF; Pérez A; St-Pierre S; Huidobro-Toro JP
Peptides; 1989; 10(3):551-8. PubMed ID: 2571139
[TBL] [Abstract][Full Text] [Related]
13. Effect of some new beta-adrenergic blocking agents on certain metabolic responses to catecholamines.
Kvam DC; Riggilo DA; Lish PM
J Pharmacol Exp Ther; 1965 Aug; 149(2):183-92. PubMed ID: 5831041
[No Abstract] [Full Text] [Related]
14. Involvement of central alpha-pressor and beta-depressor adrenoceptors in the cardiovascular response to intracerebroventricular catecholamines in the rat.
Peres-Polon VL; Corrêa FM
Gen Pharmacol; 1987; 18(2):159-64. PubMed ID: 3032731
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of actions of catecholamines by a derivative of hemicholinium.
Wong S; Long JP
J Pharmacol Exp Ther; 1967 Jun; 156(3):469-82. PubMed ID: 4381801
[No Abstract] [Full Text] [Related]
16. Potentiation of catecholamines by a new diphenylalkanolamine. I. Studies in vivo and general pharmacology.
Kasuya Y; Watanabe M
Arzneimittelforschung; 1965 Nov; 15(11):1279-84. PubMed ID: 4382189
[No Abstract] [Full Text] [Related]
17. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs.
Setler PE; Pendleton RG; Finlay E
J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964
[TBL] [Abstract][Full Text] [Related]
18. Acidosis induced by catecholamines and reduction of cardiovascular responses to catecholamines in acidosis.
Atkinson JM; Dusting GJ; Rand MJ
Aust J Exp Biol Med Sci; 1972 Dec; 50(7):847-59. PubMed ID: 4658842
[No Abstract] [Full Text] [Related]
19. Prostaglandins as adrenergic antagonists.
Steinberg D
Ann N Y Acad Sci; 1967 Feb; 139(3):897-909. PubMed ID: 4292400
[No Abstract] [Full Text] [Related]
20. Effect of catecholamines and adrenergic antagonists on blood glucose, free fatty acids and liver glycogen levels in fed rats.
Bugajski J; Hano J; Zdebska A
Pol J Pharmacol Pharm; 1978; 30(6):799-818. PubMed ID: 755244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
